Abaxx Technologies is fighting back against a short-seller report with lawyers, regulators, and trading data.1 Viceroy Research published a report alleging misconduct at Abaxx, a move the company calls a short-and-distort attack designed to push the stock down for profit.1
Abaxx retained law firm Paul Weiss to investigate Viceroy's claims.1 The company also engaged two regulators directly: Singapore's Monetary Authority (MAS) and Canada's CIRO.1 The CIRO outreach goes further than a standard rebuttal — Abaxx asked the regulator to examine Viceroy's own trading activity around the report's release.1 That request shifts scrutiny onto the short-seller itself, a tactic companies increasingly use when they suspect a report was timed to profit from a stock drop.1
Abaxx has publicly labeled the Viceroy report misinformation.1 The company is pairing that message with operational proof: Abaxx Exchange posted its best trading month on record in June 2026.1 Record volume during the same window as the attack undercuts Viceroy's narrative with hard numbers rather than just denials.1
The dispute touches both securities and regulatory domains, and market sentiment on Abaxx has been mixed but improving since the report emerged.1 The playbook here — outside counsel, dual regulatory engagement, and public data releases — mirrors how other exchanges and issuers have responded to short-seller campaigns in past years, though Abaxx's move to trigger a regulatory probe into the short-seller's own trading is a more aggressive counter than most companies attempt.
For investors, the case underscores a broader dynamic in markets: short-and-distort reports can move share prices quickly, but companies with strong underlying operating data have more room to fight back credibly. Abaxx's record trading volume gives its rebuttal a concrete data point that a written denial alone would lack.
Regulators at MAS and CIRO have not yet issued findings on either the original allegations or Abaxx's counter-complaint about Viceroy's trading. The outcome of those reviews will determine whether Abaxx's defense holds or whether Viceroy's claims gain traction.
